|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Atopic Dermatitis | |||||
| Eczema Herpeticum | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Dermatitis | |||||
| Dermatitis, Atopic | |||||
| Eczema | |||||
| Kaposi Varicelliform Eruption | |||||
| 3 | More general conditions related to this trial | ||||
| DNA Virus Infections | |||||
| Genetic Diseases, Inborn | |||||
| Herpes Simplex | |||||
| Herpesviridae Infections | |||||
| Hypersensitivity | |||||
| Hypersensitivity, Immediate | |||||
| Immune System Diseases | |||||
| Skin Diseases | |||||
| Skin Diseases, Eczematous | |||||
| Skin Diseases, Genetic | |||||
| Skin Diseases, Infectious | |||||
| Skin Diseases, Viral | |||||
| Virus Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Allergy and Infectious Diseases (NIAID) | |||||